News
The benchmark U.S. 10-year Treasury bond yield is near 4.5%. The yield was headed toward the key 5% threshold in April on hotter-than-expected inflation data, but turned lower after the May ...
In a report released today, Florent Cespedes from Bernstein maintained a Buy rating on GlaxoSmithKline (GSK – Research Report), with a price ...
Let's discuss these factors in detail to understand how to play GSK’s stock amid the recent price decline. GSK Specialty Medicines Unit on a Strong Footing GSK is witnessing increased sales ...
Explore how U.S. tariffs and vaccine skepticism may impact GSK plc's profitability. Click for my update as tariffs are ...
Deutsche Bank analyst Emmanuel Papadakis maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...
Utilizing one-week price change and the monthly percentage ... Momentum investors should take note of this Medical stock. GSK has a Momentum Style Score of A, and shares are up 7.3% over the ...
GSK’s share price has fallen a long way from its one-year high, which has only increased the major undervaluation I’d seen in the stock before that. When investing, your capital is at risk.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results